Baseline levels of coagulation parameters in FVL patients and controls
| . | Baseline values (mean ± IQR, range) . | P . | |
|---|---|---|---|
| FVL . | Controls . | ||
| Fibrinogen Clauss, g/L | 2.70 ± 0.70 (2.10-4.30) | 2.50 ± 0.68 (2.10-3.90) | .430 |
| Sekisui SF, mg/L | 5.40 ± 4.18 (0.70-10.60) | 5.10 ± 4.50 (2.80-28.20) | .948 |
| Iatron SF, mg/L | 5.80 ± 1.38 (5.00-9.40) | 7.25 ± 1.20 (4.20-9.00) | .038 |
| TINAquant D-dimer, mg/L | 0.31 ± 0.28 (0.04-1.14) | 0.10 ± 0.08 (0.02-0.24) | .014 |
| Iatron FDP-P, mg/L | 3.20 ± 1.05 (2.40-4.70) | 2.20 ± 0.50 (1.60-3.00) | < .001 |
| PPIC, μg/L | 230.2 ± 99.4 (172.7-476.3) | 194.2 ± 79.2 (152.5-336.3) | .064 |
| TINAquant D-dimer (Serum), mg/L | 0.25 ± 0.22 (0.07-0.95) | 0.10 ± 0.12 (0.00-0.19) | .001 |
| . | Baseline values (mean ± IQR, range) . | P . | |
|---|---|---|---|
| FVL . | Controls . | ||
| Fibrinogen Clauss, g/L | 2.70 ± 0.70 (2.10-4.30) | 2.50 ± 0.68 (2.10-3.90) | .430 |
| Sekisui SF, mg/L | 5.40 ± 4.18 (0.70-10.60) | 5.10 ± 4.50 (2.80-28.20) | .948 |
| Iatron SF, mg/L | 5.80 ± 1.38 (5.00-9.40) | 7.25 ± 1.20 (4.20-9.00) | .038 |
| TINAquant D-dimer, mg/L | 0.31 ± 0.28 (0.04-1.14) | 0.10 ± 0.08 (0.02-0.24) | .014 |
| Iatron FDP-P, mg/L | 3.20 ± 1.05 (2.40-4.70) | 2.20 ± 0.50 (1.60-3.00) | < .001 |
| PPIC, μg/L | 230.2 ± 99.4 (172.7-476.3) | 194.2 ± 79.2 (152.5-336.3) | .064 |
| TINAquant D-dimer (Serum), mg/L | 0.25 ± 0.22 (0.07-0.95) | 0.10 ± 0.12 (0.00-0.19) | .001 |